Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Handbook of Experimental Pharmacology|February 27, 2026
Role of Innate Immune Receptors in Cardiac Damage Linked to Metabolic DisordersAlmudena Val-Blasco, Marta Gil-Fernández, Andrea Bueno-Sen, et al.
Acta Physiologica (Oxford, England)|May 22, 2021
Ca<sup>2+</sup> mishandling in heart failure: Potential targetsAlmudena Val-Blasco, Marta Gil-Fernández, Angélica Rueda, et al.
JACC. Basic to Translational Science|August 8, 2020
Innate Immune Receptors, Key Actors in Cardiovascular DiseasesRafael I Jaén, Almudena Val-Blasco, Patricia Prieto, et al.
International Journal of Molecular Sciences|September 13, 2025
Atrial Myopathy and Heart Failure: Immunomolecular Mechanisms and Clinical ImplicationsMarta Gil Fernández, Andrea Bueno Sen, Paula Cantolla Pablo, et al.
International Journal of Molecular Sciences|May 28, 2022
The Aryl Hydrocarbon Receptor Ligand FICZ Improves Left Ventricular Remodeling and Cardiac Function at the Onset of Pressure Overload-Induced Heart Failure in MiceMaría Tamayo, Laura Martín-Nunes, María José Piedras, et al.
Frontiers in Physiology|July 3, 2018
Deficiency of NOD1 Improves the β-Adrenergic Modulation of Ca<sup>2+</sup> Handling in a Mouse Model of Heart FailureAlmudena Val-Blasco, Jose A Navarro-García, Maria Tamayo, et al.
International Journal of Molecular Sciences|November 26, 2020
Genetic Deletion of NOD1 Prevents Cardiac Ca<sup>2+</sup> Mishandling Induced by Experimental Chronic Kidney DiseaseMarta Gil-Fernández, José Alberto Navarro-García, Almudena Val-Blasco, et al.
Journal of the American Heart Association|February 12, 2026
Fibroblast Growth Factor 23 as a Prognostic Biomarker in Post-Myocardial Infarction Outcomes: Influence of Renal Function and Its Modulation by KlothoSara Vázquez-Sánchez, Ana Blasco, Marina Polo-Salguero, et al.
JACC. Basic to Translational Science|July 12, 2022
Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca<sup>2+</sup> Handling and NRF2 ActivationAlmudena Val-Blasco, Patricia Prieto, Rafael Iñigo Jaén, et al.
Pageof 2